Loading...
Presentation Type
Clinical Research
Recommended Citation
[1] Vos, Miriam B., et al. “NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: R.” NASPGHAN, JPGN Volume 64, Number 2, Feb. 2024 [2] Ferraioli, G., Calcaterra, V., Lissandrin, R. et al. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter. BMC Gastroenterol 17, 61 (2017) [3] Hampl et al. Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics February 2023 [4] Armstrong, S. C., Bolling, C. F., Michalsky, M. P., & Reichard, K. W. (2019). Pediatric metabolic and bariatric surgery: Evidence, barriers, and best practices. Pediatrics (Evanston), 144(6) [5] Weghuber, D., Barrett, T., Barrientos-Pérez, M., Gies, I., Hesse, D., Jeppesen, O. K., Kelly, A. S., Mastrandrea, L. D., Sørrig, R., & Arslanian, S. (2022). Once-WeeklySemaglutide in Adolescents with Obesity. The New England Journal of Medicine, 387(24), 2245–2257 [6] Michalsky, M. P., Inge, T. H., Simmons, M., Jenkins, T. M., Buncher, R., Helmrath, M., Brandt, M. L., Harmon, C. M., Courcoulas, A., Chen, M., Horlick, M., Daniels, S. R., & Urbina, E. M. (2015). Cardiovascular Risk Factors in Severely Obese Adolescents: The Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Study. JAMA Pediatrics, 169(5), 438–444.
Included in
Evaluating the Impact of Weight Loss Interventions on Non-Alcoholic Fatty Liver Disease in Pediatric Patients: A Preliminary Analysis Using Transient Elastography